A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies

Autor:	Anand Jillella, Sonia Leadmon, Michael Craig, Aaron Cumpston, Vamsi Kota, Kathy Watkins, Mehdi Hamadani, David L. DeRemer, Samith Thomas Kochuparambil, Jeremy Pantin, Farrukh T. Awan
Rok vydání:	2013
Předmět:	Transplantation Mobilization Cyclophosphamide business.industry Plerixafor Hematology medicine.disease Granulocyte colony-stimulating factor hemic and lymphatic diseases Immunology medicine Cancer research In patient Progenitor cell business Multiple myeloma medicine.drug
Zdroj:	Biology of Blood and Marrow Transplantation. 19(2):S182-S183
ISSN:	1083-8791
DOI:	10.1016/j.bbmt.2012.11.176
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6452f7fb32f2e8fc436ab2b21ff5d7b4 Zobrazit plný text záznamu Full Text from ScienceDirect